Skin cell targeting with self-assembled ligand addressed nanoemulsion droplets

International Journal of Cosmetic Science

Volumn 35, Issue 3, 2013, Pages 310-318

  Atrux Tallau, N ^a,b   Delmas, T ^b   Han, S H ^c   Kim, J W ^d   Bibette, J ^a  

^a PSL RESEARCH UNIVERSITY   (France)

^b Capsum   (France)

^c AmorePacific Corporation   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

amorphicity; encapsulation; fibroblast; keratinocyte; nanoemulsion; targeting

Indexed keywords

CAMELINA SATIVA EXTRACT; COSMETIC; MELIA AZADIRACHTA EXTRACT; NANOCARRIER; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; BIOAVAILABILITY; CAMELINA SATIVA; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FOLLOW UP; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MEDICINAL PLANT; MELIA AZADIRACHTA; NANOEMULSION; NANOENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; SKIN CELL; SKIN FIBROBLAST; TARGET CELL;

ADSORPTION; EMULSIONS; LIGANDS; NANOSTRUCTURES; SKIN;

EID: 84877807924     PISSN: 01425463     EISSN: 14682494     Source Type: Journal    
DOI: 10.1111/ics.12044     Document Type: Article

References (32)

1. Leal-Calderon, F., Schmitt, V., and, Bibette, J., Emulsion Science-Basic Principles, 2nd edn. Springer Science+Business Media, New York, USA (2007).
2. Constantinides, P.P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12, 1561-1572 (1995).
3. Mehta, S.K., and, Kaur, G., Microemulsions as carriers for therapeutic molecules. Recent Pat. Drug Deliv. Formul. 4, 35-48 (2010).
4. Delmas, T., Piraux, H., Couffin, A.-C., et al,. How to prepare and stabilize very small nanoemulsions. Langmuir 27, 1683-1692 (2010).
5. Egger, H., and, McGrath, K.M., Aging of oil-in-water emulsions: the role of the oil. J. Colloid Interface Sci. 299, 890-899 (2006).
6. Webster, A.J., and, Cates, M.E., Stabilization of Emulsions by Trapped Species. Langmuir 14, 2068-2079 (1998).
7. Wooster, T.J., Golding, M., and, Sanguansri, P., Impact of oil type on nanoemulsion formation and Ostwald ripening stability. Langmuir 24, 12758-12765 (2008).
8. Sonneville-Aubrun, O., Simonnet, J.T., and, L'Alloret, F., Nanoemulsions: a new vehicle for skincare products. Adv. Colloid Interface Sci. 108-109, 145-149 (2004).
9. Delmas, T., Couffin, A.-C., Bayle, P.A., et al,. Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tuneable viscosity. J. Colloid Interface Sci. 360, 471-481 (2011).
10. Atrux-Tallau, N., Falson, F., and, Pirot, F., Nanotherapeutics for skin diseases. In: Nanotherapeutics-Drug Delivery Concepts in Nanoscience (, Lamprecht, A., ed.), pp. 125-161. Pan Stanford Publishing Pvt Ltd., Singapore (2009).
11. Lboutounne, H., Faivre, V., Falson, F., and, Pirot, F., Characterization of transport of chlorhexidine-loaded nanocapsules through hairless and wistar rat skin. Skin Pharmacol. Physiol. 17, 176-182 (2004).
12. Tadros, T., Izquierdo, P., Esquena, J., and, Solans, C., Formation and stability of nano-emulsions. Adv. Colloid Interface Sci. 108-109, 303-318 (2004).
13. Bunschoten, A., Buckle, T., Kuil, J., Luker, G.D., Luker, K.E., Nieweg, O.E., and, van Leeuwen, F.W.B., Targeted non-covalent self-assembled nanoparticles based on human serum albumin. Biomaterials 33, 867-875 (2012).
14. Crombez, L., Charnet, A., Morris, M.C., Aldrian-Herrada, G., Heitz, F., and, Divita, G., A non-covalent peptide-based strategy for siRNA delivery. Biochem. Soc. Trans. 35 (Pt 1), 44-46 (2007).
15. Crombez, L., Morris, M.C., Heitz, F., and, Divita, G., A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery. Methods Mol. Biol. 764, 59-73 (2011).
16. Abu Samah, N.H., and, Heard, C.M., Topically applied KTTKS: a review. Int. J. Cosmet. Sci. 33, 483-490 (2011).
17. Aziz, Z., Davey, M., Power, J., Anthony, P., Smith, R., and, Lowe, K., Production of asiaticoside and madecassoside in Centella asiatica in vitro and in vivo. Biol. Plant. 51, 34-42 (2007).
18. Goutayer, M., Dufort, S., Josserand, V., et al,. Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur. J. Pharm. Biopharm. 75, 137-147 (2010).
19. Texier, I., Goutayer, M., Da Silva, A., et al,. Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging. J. Biomed. Opt. 14, 054005 (2009).
20. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A., and, Fusenig, N.E., Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106, 761-771 (1988).
21. Gravier, J., Navarro, F.P., Delmas, T., et al,. Lipidots: competitive organic alternative to quantum dots for in vivo fluorescence imaging. J. Biomed. Opt. 16, 096013 (2011).
22. Hancock, B.C., and, Parks, M., What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17, 397-404 (2000).
23. Muller, R.H., Radtke, M., and, Wissing, S.A., Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 242, 121-128 (2002).
24. Westesen, K., Bunjes, H., and, Koch, M.H.J., Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Controlled Release 48, 223-236 (1997).
25. Delmas, T., Fraichard, A., Bayle, P.A., et al,. Encapsulation and release behavior from lipid nanoparticles: model study with nile red fluorophore. J. Colloid Sci. Biotechnol. 1, 16-25 (2012).
26. Maupas, C., Moulari, B., Beduneau, A., Lamprecht, A., and, Pellequer, Y., Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells. Int. J. Pharm. 411, 136-141 (2011).
27. Weyenberg, W., Filev, P., Van den Plas, D., et al,. Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. Int. J. Pharm. 337, 291-298 (2007).
28. Olschlager, V., Schrader, A., and, Hockertz, S., Comparison of primary human fibroblasts and keratinocytes with immortalized cell lines regarding their sensitivity to sodium dodecyl sulfate in a neutral red uptake cytotoxicity assay. Arzneimittelforschung 59, 146-152 (2009).
29. Katayama, K., Armendariz-Borunda, J., Raghow, R., Kang, A.H., and, Seyer, J.M., A pentapeptide from type I procollagen promotes extracellular matrix production. J. Biol. Chem. 268, 9941-9944 (1993).
30. Hashim, P., Sidek, H., Helan, M.H., Sabery, A., Palanisamy, U.D., and, Ilham, M., Triterpene composition and bioactivities of Centella asiatica. Molecules 16, 1310-1322 (2011).
31. Tang, B., Zhu, B., Liang, Y., et al,. Asiaticoside suppresses collagen expression and TGF-beta/Smad signaling through inducing Smad7 and inhibiting TGF-betaRI and TGF-betaRII in keloid fibroblasts. Arch. Dermatol. Res. 303 563-572 (2011).
32. Sampson, J.H., Raman, A., Karlsen, G., Navsaria, H., and, Leigh, I.M., In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins. Phytomedicine 8, 230-235 (2001).